HUTCHMED (China) (HMDCF) Non Operating Income (2018 - 2021)
HUTCHMED (China) (HMDCF) reported Non Operating Income of $3.0 million for Q2 2021, up 624.94% year-over-year from $413000.0 in Q2 2020, and up 921.84% quarter-over-quarter from $293000.0 in Q1 2021.
HUTCHMED (China) (HMDCF) Non Operating Income (2018 - 2021) Analysis & Trends
HUTCHMED (China) (HMDCF) has 4 years of Non Operating Income data on file, last reported at $3.0 million in Q2 2021.
- Non Operating Income for Q2 2021 came in at $3.0 million, up 624.94% year-over-year; the trailing twelve-month figure through Jun 2021 was $4.9 million (up 54.37% YoY), and the FY2025 annual result was $61.0 million, up 43.09% from the prior year.
- Non Operating Income advanced to $3.0 million in Q2 2021 per HMDCF's latest filing, from $293000.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $3.0 million in Q2 2021 and troughed at -$31000.0 in Q4 2019.
- A 4-year average of $1.3 million and a median of $1.2 million in 2018 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2019 and 2021: Non Operating Income slumped 102.8% in 2019, then jumped 624.94% in 2021.
- A 4-year view of Non Operating Income shows it stood at $1.1 million in 2018, then tumbled by 102.8% to -$31000.0 in 2019, then surged by 1432.26% to $413000.0 in 2020, then jumped by 624.94% to $3.0 million in 2021.
- Business Quant data shows HMDCF's Non Operating Income at $3.0 million in Q2 2021, $293000.0 in Q1 2021, and $413000.0 in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 5.71 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -23.23 Mn |
| 10 | HUTCHMED (China) | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 2.99 Mn |
| Mar 31, 2021 | 293,000.00 |
| Jun 30, 2020 | 413,000.00 |
| Mar 31, 2020 | 1.17 Mn |
| Dec 31, 2019 | -31,000.00 |
| Sep 30, 2019 | 1.60 Mn |
| Jun 30, 2019 | 2.57 Mn |
| Mar 31, 2019 | 1.14 Mn |
| Dec 31, 2018 | 1.11 Mn |
| Sep 30, 2018 | 1.69 Mn |
| Jun 30, 2018 | 2.04 Mn |
| Mar 31, 2018 | 1.15 Mn |